These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 23388484
1. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M. J Physiol Pharmacol; 2012 Dec; 63(6):677-82. PubMed ID: 23388484 [Abstract] [Full Text] [Related]
2. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K. Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909 [Abstract] [Full Text] [Related]
3. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. Koetz KR, Ventz M, Diederich S, Quinkler M. J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966 [Abstract] [Full Text] [Related]
4. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Xu S, Wang Y, Lu J, Xu J. Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136 [Abstract] [Full Text] [Related]
10. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. Monegal A, Navasa M, Peris P, Alvarez L, Pons F, Rodés J, Guañabens N. Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189 [Abstract] [Full Text] [Related]
11. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ceccato F, Barbot M, Albiger N, Zilio M, De Toni P, Luisetto G, Zaninotto M, Greggio NA, Boscaro M, Scaroni C, Camozzi V. Eur J Endocrinol; 2016 Aug; 175(2):101-6. PubMed ID: 27185866 [Abstract] [Full Text] [Related]
12. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. Zhao HY, Liu JM, Ning G, Zhao YJ, Chen Y, Sun LH, Zhang LZ, Xu MY, Chen JL. Osteoporos Int; 2008 Feb; 19(2):221-6. PubMed ID: 17703270 [Abstract] [Full Text] [Related]
13. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis]. Vaňuga P, Ságová I. Vnitr Lek; 2021 Feb; 67(5):264-269. PubMed ID: 35459392 [Abstract] [Full Text] [Related]
17. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. Rouster-Stevens KA, Langman CB, Price HE, Seshadri R, Shore RM, Abbott K, Pachman LM. Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075 [Abstract] [Full Text] [Related]